Professional Documents
Culture Documents
Congestive heart
failure, 6%
Coronary heart
Stroke, 18% disease, 54%,
The FACTS
60
50
50
40
40
30
30
20
20
10 10
0
0
2-15 16-20 21-25 26-39
2-15 16-20 21-25 26-39
age(yrs)
Age (yrs)
Infant Adult
Necropsy evaluation
Atherosclerotic lesions begins in individuals
from
2-39 years old
Evidence : classic vascular risk factors are
relevant to these initial stages
of vessel pathology
PDAY research group :
Atherosclerosis. 2002;160: 441-448
Arterioscler.Thromb Vasc Biol.2000;20:1998-2004
Stages of Atherosclerosis
ATHEROSCLEROSIS:
Pathology, Pathogenesis, Complications, Natural History
Leeson P. Pediatrics 2007;6: 1203-06
Natural history of Atherosclerosis
Transition from risk factors to atherosclerosis mediated
by endothelial dysfunction
Pharmacological Report 2006;58:Suppl 33-40
Impaired FMD(%) in Famalial
Hypercholesterolemia
Munir 195.7 31
Andriastuti 166.7 16
Gerung 166.2
rs
rs
s
21 s
Yr
r
5Y
9Y
0y
aortas
15
-2
-2
-3
2-
16
26
Berenson GS, Srinivasan SR, Weihang B, Newman WP, etal. Association between multiple cardiovascular risk
factors and atherosclerosis in children and young adults. N Engl J Med 1998;338:1650-6.
Effect of Multiple risk factors on the extent
of atherosclerosis
JAMA 2004;291:2204-11
Non-invasive methods to
assess precelinical
Atherosclerosis
1. Functional measures
Flow mediated dilation (FMD)
2. Structural measures
Intima media thickness (IMT)
Distensibility
Pulse wave velocity
Flow Mediated
Dilation(FMD)
Brachial
artery
To measure the
vasodilator response
showing the realease
NO (nitrix oxide)
Decreased FMD :
ENDOTHELIAL DYSFUNCTION “shear stress “
which is a RISK FACTOR ofCVD
phenomen induced
in later life
vasorelaxation
Intima Media Thickness
2.Nutrient supplements-dietary
modification
L- arginine supplementation
improved endothelial function
Therapaeutics Strategies for
Vascular restoration in early life
3. Pharmacological risk factor
modification
Lipid lowering therapy improves endothelial
function (Statin treatment)
4. Gen and cell based therapies for
atherosclerosis
Promising tools for both protection and
restoration of myocardium
Target : antioxidant enzymes &
anti-inflammatory cytokines
PDAY :
Atheroscleosis begins in childhood